Nephrocare Health IPO to open on December 10: Here's a look at objectives, key dates and more

Nephrocare Health IPO: The initial public offering of end-to-end dialysis care services provider Nephrocare Health Services Ltd will open on December 10. The issue will conclude on December 12. The price band has not been announced yet.

The initial share sale is a fresh issuance of ₹353.41 crore and an offer for sale of 11,253,102 shares, according to the red herring prospectus.

Under the OFS, promoters Investcorp Private Equity Fund II, Healthcare Parent, Edoras Investment Holdings Pte Ltd and Investcorp Growth Opportunity Fund will sell their stake. Additionally, investors Investcorp India Private Equity Opportunity, International Finance Corporation, 360 One Special Opportunities Fund - Series 10 and 360 One Special Opportunities Fund - Series 9 will also offload their shares.

The fresh issue proceeds will be used for opening new dialysis clinics in India, debt repayment and general corporate purposes.

"Our company expects to receive the benefits of listing of the equity shares on the stock exchanges, including, among other things, enhancement of our company’s brand name among existing and potential customers and the creation of a public market for the equity shares in India," the firm said in its RHP.

Nephrocare Health IPO: Timeline

Nephrocare Health provides comprehensive dialysis care via a network of clinics – from diagnosis to treatment and wellness programmes, including haemodialysis, mobile and home dialysis, supported by pharmacy.

It is India’s largest dialysis service provider on the basis of patients served, clinics, cities covered, treatments performed, revenue, and EBITDA (excluding other income) in Fiscal 2025.

According to the F&S Report, it is the only Indian dialysis services provider that has scaled internationally with a global network of 519 clinics, including 51 clinics across the Philippines, Nepal and Uzbekistan, as of September 30, 2025.